Immune dysfunction in cancer patients.
Explore this paper's citation graph
Summary
This review will encompass the major mechanisms responsible for tumor evasion of immune surveillance and highlight a role for VEGF as a principal contributor to tumor-associated immune deficiencies.
- Type
- article
- Published
- 2002-01-01
- Cited by
- 69
- References
- 56
- OpenAlex
- https://openalex.org/W3736273
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:269645
Keywords
Immune system, Cancer, Immunology, Antigen, Antigen presentation
References
- Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor.
- Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.
- The immune system as anti-tumor sentinel: molecular requirements for an anti-tumor immune response.
- Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.
- Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas.
- Early Block in Maturation Is Associated with Thymic Involution in Mammary Tumor-Bearing Mice1
- Identification of genes encoding T cell defined tum- antigens.
- Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses.
- Toward a genetic analysis of tumor rejection antigens.
- Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation.
- New insights into the roles of ReL/NF-kappa B transcription factors in immune function, hemopoiesis and human disease.
- The biology of vascular endothelial growth factor.
- Tumor Suppressor Gene-Derived Peptide Antigens
- Molecular and biological properties of the vascular endothelial growth factor family of proteins.
- T cells and aging (update february 1999).
- Immunologic nonresponsiveness to tumors.
- NF-kappa B: ten years after.
- Escape from host-antitumor immunity.
- Where have all the T cells gone? Mechanisms of immune evasion by tumors.
- Association of Vascular Endothelial Growth Factor Expression with Tumor Angiogenesis and with Early Relapse in Primary Breast Cancer
Cited by
- A Phase II Study of ABT-510 (Thrombospondin-1 Analog) for the Treatment of Metastatic Melanoma
- New understanding on the pathogenesis of acute arterial thrombosis
- Immunological Aspects of Neoplasia — The Role of the Thymus
- Effect of Herbal Therapy on Intracellular Cytokine Expression of CD8 Cell in Nasopharingeal Cancer Patients
- Immunoregulation by hepatocyte growth factor in malignant mesothelioma
- Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
- Signalling molecules and cytokine production in T cells of multiple myeloma‐increased abnormalities with advancing stage
- Harnessing Dendritic Cells for Tumor Antigen Presentation
- Visualization of tumor-induced VEGF expression using in vivo bioluminescence
- Dendritic cell vaccination and immunostimulation in advanced melanoma
- Cachexia induced by Walker 256 tumor growth causes rat lymphocyte death
- Angiogenesis in health and disease
- Hemodynamic Responses to Visual Stimulation in Children with Sickle Cell Anemia
- The regulatory effects of interleukin-12 on interleukin-18 and interferon-γ production in Egyptian breast cancer patients
- Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapy
- Modulation of prostaglandin activity, part 1: Prostaglandin inhibition in the management of nonrheumatologic diseases: Immunologic and hematologic aspects
- Mechanisms of and strategies for overcoming resistance to anti-vascular endothelial growth factor therapy in non-small cell lung cancer.
- Direct vaccination with tumor cells killed with ICP4-deficient HSVd120 elicits effective antitumor immunity
- Manipulating angiogenesis in medicine
- Antitumor Immunity and Dietary Compounds
Related papers
- Lymphocytes and the immune response. I.
- Modulation of the immune response by systemic targeting of antigens to lymph nodes.
- The human spleen and the immune system: not just another lymphoid organ.
- [Regulation of the immune response: the TH1/TH2 concept].
- Innate immune therapy for cancer. Screen for molecules capable of activating the innate immune system.
- Antigen presentation and adaptive immune responses in skin.
- Peripheral nonresponsiveness to orally administered soluble protein antigens.
- The regulation of mucosail immune systw
- Lympho-geographical concepts in vaccine delivery.